window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 3, 2026

  • News
  • About Us
Contact Us

AI

  • Artificial Intelligence,Biotech,CDMOs & Manufacturing

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    November 6, 2025
  • Artificial Intelligence,Data Management,Market Access & Commercialization,Technology and platforms

    Veeva’s Sebastian Wurst on building the data foundation for enterprise AI

    The promise of AI in commercial biopharma is immense, with [...]

    November 7, 2025
  • Artificial Intelligence,Data Management,Market Access & Commercialization,Technology and platforms

    Most biopharma AI pilots fail to scale, survey warns, as leaders call for stronger data foundations

    A new survey of senior life sciences executives reveals that [...]

    October 25, 2025
  • Artificial Intelligence,Biomanufacturing,Digital Health,Drug Development,Technology and platforms

    The path to the autonomous lab: balancing innovation, culture, and compliance

    Laboratories across the pharmaceutical industry are moving closer to full [...]

    October 16, 2025
  • Artificial Intelligence,Clinical Development,Digital Health,Drug Development

    New AI tool offers real-time insights into clinical trial participant behavior

    Cognivia has launched Cognivia Signal, an AI-powered platform designed to [...]

    October 12, 2025
  • Artificial Intelligence,Biotech,Movers & Shakers,Research & Development,Technology and platforms

    Sapio Sciences appoints Rich Roda as chief financial officer

    Sapio Sciences has appointed Rich Roda as chief financial officer, [...]

    October 6, 2025
  • Artificial Intelligence,Clinical Trials,Digital Health,Movers & Shakers,Technology and platforms

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    October 6, 2025
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,European biotech,Research & Development

    Labguru and Titian Software rebrand as Cenevo to accelerate scientific discovery

    Labguru and Titian Software have rebranded under a unified identity, [...]

    July 31, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Partnerships & Funding,Research & Development,Technology and platforms

    AI-powered bioreactor project aims to transform biologics manufacturing

    A Canada–UK collaboration is developing an AI-driven bioreactor platform designed [...]

    July 25, 2025
  • Artificial Intelligence,Clinical Development,Pharmacovigilance,Regulatory Affairs,Research & Development

    Pistoia Alliance expands into pharmacovigilance space with launch of two new initiatives

    Collaboration efforts aim to reduce manual burden of adverse event [...]

    July 22, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Skyhawk Therapeutics reports positive nine-month interim results for SKY-0515 in Huntington’s disease
    Categories: Central Nervous System, Clinical Trials, Drug Development, Rare Diseases, Research & Development
  • iOrganBio appoints Karol Jarzabek as chief operating officer
    Categories: Biologics & Biosimilars, Cell & Gene Therapy, Healthcare leadership, Manufacturing, Movers & Shakers, Pharmaceuticals and therapeutics
  • iXCells Biotechnologies partners with Rosebud Biosciences to advance organoid models for rare diseases
    Categories: Biologics & Biosimilars, Cell & Gene Therapy, Clinical Development, Drug Development, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top